knowledge -WSS

knowledge

author：Wikipedia 2025-08-26 23:44:32 - browse：217

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Achieving telehealth equity for people with hearing loss

leisure time

WSS

Why drug prescriptions should include diagnoses

Why are elite athletes different? Take a look at their microbes

Achieving telehealth equity for people with hearing loss

Why we need to separate burnout from moral injury in health care

What would happen to your eyes if you looked at the solar eclipse?

Do masks work? RCTs can't tell us

explore

knowledge

explore

23andMe had bad news about my health. I wish a person had delivered it

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

How one medical school became remarkably diverse

Some medical students still think black patients feel less pain

BioMarin wins approval for gene therapy to treat hemophilia A

What would happen to your eyes if you looked at the solar eclipse?

How to save PrEP access — and even expand it

Why are elite athletes different? Take a look at their microbes

Medicare proposal to cover medical devices draws a mixed reaction

Disclosing genetic information: not as worrisome as once feared

explore

Should insurance cover cosmetic surgery?

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Protect nursing home residents from future pandemics

Congress: Prevent baby formula shortages by passing a new bill

J&J reports mixed data on next

Wikipedia

entertainment

leisure time

hotspot